NCT03537820 (Post op NOISE) is a clinical trial of questionnaire in All Surgery, sponsored by CHU de Reims.

Who is sponsoring NCT03537820?

NCT03537820 is sponsored by CHU de Reims.

What drugs are being tested in NCT03537820?

Interventions in NCT03537820: questionnaire.

What condition does NCT03537820 study?

NCT03537820 studies All Surgery.

Is NCT03537820 still recruiting?

NCT03537820 is currently completed. Last updated 29 October 2018.

Last reviewed 2018-10-29 · How we verify

NCT03537820: Post op NOISE

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Noise Impact in the Post-anesthesia Care Unit

Completed Last updated 29 October 2018

What this trial tests

trial testing questionnaire in All Surgery in 816 participants. Completed in 4 May 2018.

Timeline

5 March 2018

Primary endpoint
4 May 2018

4 May 2018

Quick facts

Lead sponsor	CHU de Reims
Status	Completed
Study type	OBSERVATIONAL
Enrollment	816
Start date	5 March 2018
Primary completion	4 May 2018
Estimated completion	4 May 2018
Sites	1 location across France

Drugs / interventions tested

questionnaire

Conditions studied

All Surgery — all drugs for All Surgery →

Sponsor

CHU de Reims — full company profile →

Who can join

18 and older, any sex, with All Surgery. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

World health organization recommends noise level should be less than 30db in hospital. However many analysis conclude to an average of 67dB in the post anesthesia care unit. No many studies were reported about noise impact in a post-anesthesia care unit. Only one was published by B.Allaouchiche in 2002. However, noise is a complaint reported by patients and it could be responsible for physiological and psychological troubles. In this prospective study, the main objective is to determine patients' satisfaction in the post anesthesia care unit, before and after installation of a noise warning device. Between the two parts, a short training about noise consequences on health will be presented to nurses. Improvement off anti-noise actions on patient's satisfaction will analysed.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other CHU de Reims trials

Trials by the same sponsor.

NCT06955767 — Measurement of MMP-14 Protein, a Potential New Marker for Colorectal Cancer Detection, in Plasma Vesicles Named Exosomes · NA · recruiting
NCT07163338 — Prevalence and Consequences of Antiphospholipid Syndrome in Patients Aged 65 and Over With Ischemic Strokes (IS) · NA · recruiting
NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting
NCT06782997 — Performance of the Electroretinogram, Performed and Interpreted by an Advanced Practice Nurse, in the Screening for Diab · recruiting
NCT07016035 — Translation and Validation of the French mPCOSQ (mPCOSQ-F). · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03537820 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by CHU de Reims
Last refreshed: 29 October 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03537820.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing